Drugs.com - Pharma Industry News

Multitarget Stool DNA Tests More Costly Than FIT for Colorectal Cancer Detection

WEDNESDAY, May 14, 2025 -- Multitarget stool DNA test (MSDT)- and next-generation MSDT (N-G MSDT)-based screening have higher costs per detected advanced neoplasia case or early colorectal cancer (CRC) case than fecal immunochemical tests (FITs)...

May 15, 2025 - 00:56
 0
Multitarget Stool DNA Tests More Costly Than FIT for Colorectal Cancer Detection
WEDNESDAY, May 14, 2025 -- Multitarget stool DNA test (MSDT)- and next-generation MSDT (N-G MSDT)-based screening have higher costs per detected advanced neoplasia case or early colorectal cancer (CRC) case than fecal immunochemical tests (FITs)...
Read More

Tags:

Previous Article

Odds of Burnout Higher for Doctors Working With Incompletely Staffed Team

Next Article

Pathological Fatigue Common Up to 12 Months After TIA

Related Posts

Power Outages Up Odds of Carbon Monoxide-Related ED Visits Among Children

Power Outages Up Odds of Carbon Monoxide-Related ED Vis...

May 6, 2025  0

Female Ophthalmology Trainees Perform Fewer Cataract Procedures During Residency

Female Ophthalmology Trainees Perform Fewer Cataract Pr...

May 8, 2025  0

Neuromodulation Methods Show Comparable Outcomes for Neurogenic Bladder in Women With MS

Neuromodulation Methods Show Comparable Outcomes for Ne...

May 7, 2025  0